Obesity Clinical Trial
Official title:
Impact of Counseling on Obesity Surgery Outcomes and Psychological Functioning: A Randomized Clinical Trial in 2 Arab Countries
Obesity has become a global epidemic causing enormous human and economic costs. Incidence
rates have doubled over the last few decades and obesity-related illnesses such as diabetes
and cardiovascular diseases now constitute one of the major contributors to the global
burden of disability. Overall, obesity has been recognized as one of the most pressing
public health concerns worldwide and effective treatment and prevention strategies are
urgently required. While behavioral and pharmacological treatments (e.g.low calorie diets,
medication) are successful means for overcoming overweight and mild obesity, more severe
cases of obesity usually fail to respond to such interventions. As a result, the demand for
weight loss surgery is growing among this population. However, uncertainties about the
effectiveness of obesity surgery persist and high relapse rates (i.e. weight regain) are
common. Further research in this field is needed to identify risk factors that may trigger
relapse and to understand patients' treatment needs in greater depth. Previous studies have
pointed toward high levels of mental health problems among patients. However, the impact of
preoperative psychopathology on actual surgery outcomes remains unclear. Similarly, few
studies have investigated the effect of postoperative therapy on patients' psychological
functioning and weight loss patterns. Research addressing these gaps is imperative to
establish best-practice approaches. This challenge applies in particular to Middle East and
North Africa(MENA) countries where research in the field of bariatric surgery and related
mental health is largely missing. This is a major concern given the fact that the MENA
region experienced the highest increase in overweight and obesity in recent decades compared
to other countries.
The proposed study aims to address this deficiency by examining obesity surgery patients in
two Arab countries (UAE and Jordan). The goals of the project are to investigate the nature
and extent of psychological health concerns among these patients before and after surgery
and potential associations with treatment outcomes. Moreover, it will test the efficacy of
post-operative counseling to improve weight loss and psychological health. For this purpose,
a randomized clinical trial design will be employed so that cause and effect relationships
between postoperative counseling and treatment outcomes(i.e. weight loss and psychological
functioning) can be examined experimentally. The study will start by assessing participants'
psychological health prior to surgery by using standardized self-report measures.
After surgery, participants will be randomly assigned to either the intervention condition
consisting of 3-monthly post-operative medical checkups plus group counseling or the
treatment as usual condition (i.e. 3-monthly standard medical checkups only). Additionally,
participants' psychological health will be reassessed in both groups at 3, 6, 9 and 12
months after surgery. The benefit of the experimental study design is that it allows
comparing patient outcomes between groups while at the same time controlling for a wide
range of potential confounding variables.
The data collected are expected to make a significant contribution to the treatment
challenge of one of the most pressing public health concerns worldwide. Study results will
add to clinical practice by broadening and deepening our knowledge of the treatment needs of
obese patients. By identifying psychological health concerns that may threaten successful
treatment outcomes high-risk patient groups can be recognized early, which in turn may help
to reduce postoperative weight regain and other complications.
To the best of the PI's knowledge, the proposed work would be the first study of this kind
in the Arab world. Findings will be helpful for developing culturally sensitive and
evidence-based best-practice guidelines, which are vital to achieve satisfying long-term
outcomes. Moreover, study results will be relevant for research communities and
practitioners outside the MENA region since empirical support for the effectiveness of
obesity surgery remains weak internationally.
Obesity has become a global epidemic causing enormous human and economic costs. According to
the World Health Organization in 2011 overweight and obesity represent the fifth leading
risk of death globally, with 2.8 million adults dying each year as a result of excess
weight. Worldwide, estimates of overweight and obesity have reached 1.5 billion and 500
million respectively. In addition to an overall increased mortality among this population, a
large body of evidence has shown that excess weight is linked to several chronic illnesses
including cardiovascular diseases (e.g. stroke), diabetes mellitus (type 2), certain cancers
(e.g. breast and colon cancer) and osteoarthritis. Furthermore, obesity inflicts major
economic losses. Past research has confirmed that obesity is associated not only with higher
medical expenditures due to greater usage of medical services but also with increased
non-medical costs, for example due to absenteeism from work.
While the continuous rise of overweight and obesity is a major concern globally, it has
reached particular urgency in the MENA region where prevalence rates of both conditions have
risen to alarming levels. For example, two recent systematic literature reviews focusing on
the Arabian Gulf States reported overweight and obesity rates from 25 to 48% and 13 to 49%
respectively across the six countries. UAE-specific data showed obesity rates ranging from
26 to 47%. Additionally, the authors identified the UAE as the Gulf state with the highest
hypertension and diabetes rates. In fact, the 2011 UAE diabetes figure of 19% has been
confirmed to be one of the highest in the world. When looking at MENA countries outside the
Gulf, the highest obesity rates were reported for Syria and Jordan (38% and 35%,
respectively).
In order to tackle the increasing burden of obesity, effective intervention and prevention
approaches are required. While behavioral and pharmacological treatments (e.g. low calorie
diets, exercise, medication) are successful means for overcoming overweight and mild
obesity, cases of more severe obesity usually fail to respond to such interventions.
Instead, more radical measures such as bariatric surgery are typically needed to achieve
substantial weight loss. Past research has shown that most patients lose significant amounts
of weight after surgery. However, weight loss maintenance remains problematic with weight
regain and other adjustment difficulties (e.g. adapting healthy eating behaviors) being
common. Yet, little is known about the risk factors that may trigger weight relapse.
Previous research in this context has pointed toward high levels of mental health problems
among obese individuals including bariatric surgery patients. Affective, anxiety and eating
disorders (in particular binge eating symptoms) were most commonly reported with prevalence
rates reaching up to 84%. However, the impact of preoperative psychopathology on actual
surgery outcomes is not well understood. Results remain inconsistent and further research is
needed to determine whether or not psychological factors jeopardize successful surgery
outcomes. Another important question in this regard is whether postoperative interventions
that focus on patients' psychological health are helpful in sustaining the achieved weight
loss and in coping with postoperative adjustment difficulties. Until now, only few empirical
studies have addressed this question. Findings so far indicated a positive impact of
postoperative counseling on patients' weight management and overall well-being. However,
small sample sizes, differences in study methodology (e.g. qualitative vs. quantitative),
and the diversity of therapeutic interventions provided impede any firm conclusions.
In addition to these uncertainties, it is important to recognize that research in the field
of bariatric surgery and mental health has been almost entirely restricted to Western
countries. Despite repeated searches of several databases (e.g. PsycInfo, Academic Search
Premier, and Medline) and examination of bibliographies of relevant papers no matching
studies from MENA countries could be found. This lack of regional data is a major concern
given the difficulty of generalizing findings cross-culturally on the one hand and the high
obesity rates in this part of the world on the other. MENA-based research in this field
would yield vital insights for policy makers, commissioners and practitioners in the
management and delivery of evidence-based best-practice and patient-oriented care.
Therefore, the proposed study aims to:
1. Examine psychological health before and after bariatric surgery among obese patients in
the UAE and Jordan
2. Investigate the impact of patients' psychological health on postoperative weight loss,
and
3. Assess the efficacy of group-based counseling to improve patient outcomes (i.e. weight
loss and psychological health) after bariatric surgery
The study hypotheses are as follows:
1. Participants with higher levels of psychological health problems before surgery will
lose less weight (in %) during the first 12 months after surgery than patients with
lower levels of psychological health problems.
2. Participants who receive postoperative counseling in addition to standard treatment
will lose more weight (in %) during the first 12 months after surgery than patients who
are provided with standard treatment only.
3. Participants who receive postoperative counseling in addition to standard treatment
will show less psychological health problems at 12 months after surgery than patients
who are provided with standard treatment only.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |